인쇄하기
취소

Ilyang Pharm confirms effect of treating Parkinson’s disease treatment from leukemia treatment ‘Supect’

Published: 2017-08-04 13:30:57
Updated: 2017-08-04 13:30:57

‘Radotinib(product name: Supect),’ a leukemia treatment developed by Ilyang Pharmaceutical, showed a clinical trial result that it had an effect of treating ‘Parkinson’s disease’ as well.

Ilyang Pharm announced on the 26th that a research team at Johns Hopkins University conducted mechanism, cell and animal studies for a year to figure out the radotinib’s effect of treating ‘Parkinson’s diseas...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.